Maharaja Aggarsain Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 21-12-2024
- Paid Up Capital ₹ 1.00 M
as on 21-12-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 1.80 M
as on 21-12-2024
About Maharaja Aggarsain Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Singla Rajesh and Darshana serve as directors at the Company.
- CIN/LLPIN
U24232HR2007PTC037083
- Company No.
037083
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2007
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Hisar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Maharaja Aggarsain Pharmaceuticals Private Limited offer?
Maharaja Aggarsain Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Hand Sanitizers & Personal Hygiene, Toothpastes, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Diabetic Herbal Medicine, Ayurvedic & Herbal Health Supplement, Herbal Juice, Herbal Supplements.
Who are the key members and board of directors at Maharaja Aggarsain Pharmaceuticals?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Singla Rajesh | Director | 06-Aug-2007 | Current |
Darshana | Director | 17-Aug-2021 | Current |
Financial Performance of Maharaja Aggarsain Pharmaceuticals.
Maharaja Aggarsain Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Maharaja Aggarsain Pharmaceuticals?
In 2017, Maharaja Aggarsain Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of Patiala Creation Date: 17 Jul 2013 | ₹1.80 M | Satisfied |
How Many Employees Work at Maharaja Aggarsain Pharmaceuticals?
Unlock and access historical data on people associated with Maharaja Aggarsain Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maharaja Aggarsain Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maharaja Aggarsain Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.